Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

8.34
BATS BZX Real-Time Price
As of 11:57am ET
 +0.07 / +0.85%
Today’s Change
7.80
Today|||52-Week Range
18.00
-15.59%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$904.9M

Company Description

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. It also offers programs in clinical development for diabetes, irritable bowel syndrome, and carcinoid syndrome. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.

Contact Information

Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands Texas 77381-1160
P:(281) 863-3000
Investor Relations:
(281) 863-3383

Employees

Shareholders

Other institutional77.71%
Individual stakeholders59.62%
Mutual fund holders26.47%

Top Executives

Lonnel CoatsPresident, Chief Executive Officer & Director
Jeffrey L. WadeCFO, EVP-Corporate & Administrative Affairs
Pablo LapuertaChief Medical Officer & Executive Vice President
Alexander SantiniChief Commercial Officer & Executive VP
Alan J. MainExecutive Vice President-CMC & Supply Operations